Matches in SemOpenAlex for { <https://semopenalex.org/work/W3196527171> ?p ?o ?g. }
- W3196527171 endingPage "1230" @default.
- W3196527171 startingPage "1215" @default.
- W3196527171 abstract "Introduction The current process for generating evidence in pharmacovigilance has several limitations, which often lead to delays in the evaluation of drug-associated risks. Objectives In this study, we proposed and tested a near real-time epidemiological surveillance system using sequential, cumulative analyses focusing on the detection and preliminary risk quantification of potential safety signals following initiation of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Methods We emulated an active surveillance system in an historical setting by conducting repeated annual cohort studies using nationwide Danish healthcare data (1996–2016). Outcomes were selected from the European Medicines Agency's Designated Medical Event list, summaries of product characteristics, and the literature. We followed patients for a maximum of 6 months from treatment initiation to the event of interest or censoring. We performed Cox regression analyses adjusted for standard sets of covariates. Potential safety signals were visualized using heat maps and cumulative hazard ratio (HR) plots over time. Results In the total study population, 969,667 new users were included and followed for 461,506 person-years. We detected potential safety signals with incidence rates as low as 0.9 per 10,000 person-years. Having eight different exposure drugs and 51 medical events, we identified 31 unique combinations of potential safety signals with a positive association to the event of interest in the exposed group. We proposed that these signals were designated for further evaluation once they appeared in a prospective setting. In total, 21 (67.7%) of these were not present in the current summaries of product characteristics. Conclusion The study demonstrated the feasibility of performing epidemiological surveillance using sequential, cumulative analyses. Larger populations are needed to evaluate rare events and infrequently used antidepressants." @default.
- W3196527171 created "2021-09-13" @default.
- W3196527171 creator A5003383445 @default.
- W3196527171 creator A5006638453 @default.
- W3196527171 creator A5044826085 @default.
- W3196527171 creator A5054001832 @default.
- W3196527171 date "2021-09-08" @default.
- W3196527171 modified "2023-10-18" @default.
- W3196527171 title "Surveillance of Antidepressant Safety (SADS): Active Signal Detection of Serious Medical Events Following SSRI and SNRI Initiation Using Big Healthcare Data" @default.
- W3196527171 cites W1488312714 @default.
- W3196527171 cites W180581279 @default.
- W3196527171 cites W1978077822 @default.
- W3196527171 cites W2000445173 @default.
- W3196527171 cites W2006078781 @default.
- W3196527171 cites W2035362079 @default.
- W3196527171 cites W2042322297 @default.
- W3196527171 cites W2061326496 @default.
- W3196527171 cites W2083282685 @default.
- W3196527171 cites W2097401631 @default.
- W3196527171 cites W2099506727 @default.
- W3196527171 cites W2102420102 @default.
- W3196527171 cites W2102924526 @default.
- W3196527171 cites W2116445878 @default.
- W3196527171 cites W2123089829 @default.
- W3196527171 cites W2127590540 @default.
- W3196527171 cites W2128043538 @default.
- W3196527171 cites W2142749836 @default.
- W3196527171 cites W2145549479 @default.
- W3196527171 cites W2147108549 @default.
- W3196527171 cites W2151278054 @default.
- W3196527171 cites W2151916071 @default.
- W3196527171 cites W2152628670 @default.
- W3196527171 cites W2269807470 @default.
- W3196527171 cites W2403529042 @default.
- W3196527171 cites W2477696699 @default.
- W3196527171 cites W2767339421 @default.
- W3196527171 cites W2783818577 @default.
- W3196527171 cites W2791730844 @default.
- W3196527171 cites W2793048525 @default.
- W3196527171 cites W2884971700 @default.
- W3196527171 cites W2911910389 @default.
- W3196527171 cites W2913752772 @default.
- W3196527171 cites W2921045850 @default.
- W3196527171 cites W2926470769 @default.
- W3196527171 doi "https://doi.org/10.1007/s40264-021-01110-x" @default.
- W3196527171 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8553683" @default.
- W3196527171 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34498210" @default.
- W3196527171 hasPublicationYear "2021" @default.
- W3196527171 type Work @default.
- W3196527171 sameAs 3196527171 @default.
- W3196527171 citedByCount "5" @default.
- W3196527171 countsByYear W31965271712021 @default.
- W3196527171 countsByYear W31965271712022 @default.
- W3196527171 countsByYear W31965271712023 @default.
- W3196527171 crossrefType "journal-article" @default.
- W3196527171 hasAuthorship W3196527171A5003383445 @default.
- W3196527171 hasAuthorship W3196527171A5006638453 @default.
- W3196527171 hasAuthorship W3196527171A5044826085 @default.
- W3196527171 hasAuthorship W3196527171A5054001832 @default.
- W3196527171 hasBestOaLocation W31965271711 @default.
- W3196527171 hasConcept C104863432 @default.
- W3196527171 hasConcept C126322002 @default.
- W3196527171 hasConcept C194828623 @default.
- W3196527171 hasConcept C197636746 @default.
- W3196527171 hasConcept C197934379 @default.
- W3196527171 hasConcept C207103383 @default.
- W3196527171 hasConcept C23276603 @default.
- W3196527171 hasConcept C2426938 @default.
- W3196527171 hasConcept C2779177272 @default.
- W3196527171 hasConcept C2780092697 @default.
- W3196527171 hasConcept C2781161787 @default.
- W3196527171 hasConcept C2908647359 @default.
- W3196527171 hasConcept C44249647 @default.
- W3196527171 hasConcept C50382708 @default.
- W3196527171 hasConcept C512399662 @default.
- W3196527171 hasConcept C57658597 @default.
- W3196527171 hasConcept C71924100 @default.
- W3196527171 hasConcept C72563966 @default.
- W3196527171 hasConcept C88879693 @default.
- W3196527171 hasConcept C98274493 @default.
- W3196527171 hasConcept C99454951 @default.
- W3196527171 hasConceptScore W3196527171C104863432 @default.
- W3196527171 hasConceptScore W3196527171C126322002 @default.
- W3196527171 hasConceptScore W3196527171C194828623 @default.
- W3196527171 hasConceptScore W3196527171C197636746 @default.
- W3196527171 hasConceptScore W3196527171C197934379 @default.
- W3196527171 hasConceptScore W3196527171C207103383 @default.
- W3196527171 hasConceptScore W3196527171C23276603 @default.
- W3196527171 hasConceptScore W3196527171C2426938 @default.
- W3196527171 hasConceptScore W3196527171C2779177272 @default.
- W3196527171 hasConceptScore W3196527171C2780092697 @default.
- W3196527171 hasConceptScore W3196527171C2781161787 @default.
- W3196527171 hasConceptScore W3196527171C2908647359 @default.
- W3196527171 hasConceptScore W3196527171C44249647 @default.
- W3196527171 hasConceptScore W3196527171C50382708 @default.
- W3196527171 hasConceptScore W3196527171C512399662 @default.
- W3196527171 hasConceptScore W3196527171C57658597 @default.
- W3196527171 hasConceptScore W3196527171C71924100 @default.